Conference Coverage
Conference Coverage
National lung cancer screening guidelines may miss younger African American individuals at high risk
Retrospective analysis finds many lung cancer patients would not have counted as eligible for low-dose CT under guidelines that are being...
Conference Coverage
Adjunctive pimavanserin looks promising for anxious depression
It’s estimated that roughly 50% of individuals with major depressive disorder have comorbid anxiety disorders or a high level of anxiety symptoms...
Conference Coverage
Combined features of benign breast disease tied to breast cancer risk
Breast cancer risk was most elevated for women with proliferative benign breast disease with atypia detected on an incident screen.
Conference Coverage
Fauci: Cautious optimism for COVID-19 vaccine by end of 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.
Conference Coverage
NACMI: Clear benefit with PCI in STEMI COVID-19 patients
Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American...
Conference Coverage
Four-week, 8-week CAB/RPV injections safe, effective in women
At 48 weeks, 3.6% of women in the 8-week group had at least 50 copies/mL of HIV-1 RNA.
Latest News
Substance in tears could be used for diabetes monitoring
Measuring glycoalbumin in tears could someday be a way for patients with diabetes to monitor their glucose levels noninvasively.
Conference Coverage
Heterosexual men likely to have unmet HIV treatment needs
In high-income countries, men with HIV who had sex with men were diagnosed earlier than men with HIV who had sex with women.
Conference Coverage
Being HIV positive increases risk of death from COVID-19
For patients below the age of 70, the risk of mortality was double in people with HIV.
Conference Coverage
Switch to integrase inhibitor regimen safe and effective
Forty-eight weeks after the switch, virologic suppression was maintained among 94.3% of those on an integrase inhibitor–based regimen.
Latest News
Delayed cancer screening could cause increase in deaths, study says
Based on a survival rate of 5 years for stage 3 or stage 4 colorectal cancer, the death rate would increase nearly 12% when screening is delayed...